Cargando…
Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015
BACKGROUND: Annual seasonal influenza vaccination (SIV) is recommended for people with diabetes, but their SIV rates remain far below public health targets. We aimed to identify temporal trajectories of SIV uptake over a 10-year period among French people with diabetes and describe their clinical ch...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617633/ https://www.ncbi.nlm.nih.gov/pubmed/31288768 http://dx.doi.org/10.1186/s12889-019-7209-z |
_version_ | 1783433735263223808 |
---|---|
author | Bocquier, Aurélie Cortaredona, Sébastien Fressard, Lisa Loulergue, Pierre Raude, Jocelyn Sultan, Ariane Galtier, Florence Verger, Pierre |
author_facet | Bocquier, Aurélie Cortaredona, Sébastien Fressard, Lisa Loulergue, Pierre Raude, Jocelyn Sultan, Ariane Galtier, Florence Verger, Pierre |
author_sort | Bocquier, Aurélie |
collection | PubMed |
description | BACKGROUND: Annual seasonal influenza vaccination (SIV) is recommended for people with diabetes, but their SIV rates remain far below public health targets. We aimed to identify temporal trajectories of SIV uptake over a 10-year period among French people with diabetes and describe their clinical characteristics. METHODS: We identified patients with diabetes in 2006 among a permanent, representative sample of beneficiaries of the French National Health Insurance Fund. We followed them up over 10 seasons (2005/06–2015/16), using SIV reimbursement claims and group-based trajectory modelling to identify SIV trajectories and to study sociodemographic, clinical, and healthcare utilization characteristics associated with the trajectories. RESULTS: We identified six trajectories. Of the 15,766 patients included in the model, 4344 (28%) belonged to the “continuously vaccinated” trajectory and 4728 (30%) to the “never vaccinated” one. Two other trajectories showed a “progressive decrease” (2832, 18%) or sharp “postpandemic decrease” (1627, 10%) in uptake. The last two trajectories (totalling 2235 patients, 14%) showed an early or delayed “increase” in uptake. Compared to “continuously vaccinated” patients, those in the “progressively decreasing” trajectory were older and those in all other trajectories were younger with fewer comorbidities at inclusion. Worsening diabetes and comorbidities during follow-up were associated with the “increasing” trajectories. CONCLUSIONS: Most patients with diabetes had been continuously vaccinated or never vaccinated and thus had stable SIV behaviours. Others adopted or abandoned SIV. These behaviour shifts might be due to increasing age, health events, or contextual factors (e.g., controversies about vaccine safety or efficacy). Healthcare professionals and stakeholders should develop tailored strategies that take each group’s specificities into account. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12889-019-7209-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6617633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66176332019-07-18 Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 Bocquier, Aurélie Cortaredona, Sébastien Fressard, Lisa Loulergue, Pierre Raude, Jocelyn Sultan, Ariane Galtier, Florence Verger, Pierre BMC Public Health Research Article BACKGROUND: Annual seasonal influenza vaccination (SIV) is recommended for people with diabetes, but their SIV rates remain far below public health targets. We aimed to identify temporal trajectories of SIV uptake over a 10-year period among French people with diabetes and describe their clinical characteristics. METHODS: We identified patients with diabetes in 2006 among a permanent, representative sample of beneficiaries of the French National Health Insurance Fund. We followed them up over 10 seasons (2005/06–2015/16), using SIV reimbursement claims and group-based trajectory modelling to identify SIV trajectories and to study sociodemographic, clinical, and healthcare utilization characteristics associated with the trajectories. RESULTS: We identified six trajectories. Of the 15,766 patients included in the model, 4344 (28%) belonged to the “continuously vaccinated” trajectory and 4728 (30%) to the “never vaccinated” one. Two other trajectories showed a “progressive decrease” (2832, 18%) or sharp “postpandemic decrease” (1627, 10%) in uptake. The last two trajectories (totalling 2235 patients, 14%) showed an early or delayed “increase” in uptake. Compared to “continuously vaccinated” patients, those in the “progressively decreasing” trajectory were older and those in all other trajectories were younger with fewer comorbidities at inclusion. Worsening diabetes and comorbidities during follow-up were associated with the “increasing” trajectories. CONCLUSIONS: Most patients with diabetes had been continuously vaccinated or never vaccinated and thus had stable SIV behaviours. Others adopted or abandoned SIV. These behaviour shifts might be due to increasing age, health events, or contextual factors (e.g., controversies about vaccine safety or efficacy). Healthcare professionals and stakeholders should develop tailored strategies that take each group’s specificities into account. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12889-019-7209-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-09 /pmc/articles/PMC6617633/ /pubmed/31288768 http://dx.doi.org/10.1186/s12889-019-7209-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Bocquier, Aurélie Cortaredona, Sébastien Fressard, Lisa Loulergue, Pierre Raude, Jocelyn Sultan, Ariane Galtier, Florence Verger, Pierre Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
title | Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
title_full | Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
title_fullStr | Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
title_full_unstemmed | Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
title_short | Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
title_sort | trajectories of seasonal influenza vaccine uptake among french people with diabetes: a nationwide retrospective cohort study, 2006–2015 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617633/ https://www.ncbi.nlm.nih.gov/pubmed/31288768 http://dx.doi.org/10.1186/s12889-019-7209-z |
work_keys_str_mv | AT bocquieraurelie trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT cortaredonasebastien trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT fressardlisa trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT loulerguepierre trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT raudejocelyn trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT sultanariane trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT galtierflorence trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 AT vergerpierre trajectoriesofseasonalinfluenzavaccineuptakeamongfrenchpeoplewithdiabetesanationwideretrospectivecohortstudy20062015 |